Lumen Therapeutics
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)PolyArginine Treated vEiN grafTs (PATENT)
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2016-09-08
- Lead Sponsor
- Lumen Therapeutics
- Target Recruit Count
- 25
- Registration Number
- NCT00264706
- Locations
- π¨π¦
Toronto General Hospital, Toronto, Ontario, Canada
News
No news found